Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Elevance Health | ELV | Sep 20, 2024 | 539.86 | +0.35 |
Elevation Oncology | ELEV | Sep 20, 2024 | 0.59 | -2.32 |
Eli Lilly | LLY | Sep 20, 2024 | 921.49 | +0.70 |
Elicio Therapeutics | ELTX | Sep 20, 2024 | 5.07 | -1.36 |
Eliem Therapeutics | ELYM | Sep 20, 2024 | 8.43 | +1.81 |
Ellington Financial | EFC | Sep 20, 2024 | 13.11 | -1.06 |
Ellington Financial | EFC-B | Sep 20, 2024 | 22.45 | +0.22 |
Ellington Financial A Pref | EFC-A | Sep 20, 2024 | 25.30 | +0.22 |
Ellington Financial D Pref | EFC-D | Sep 20, 2024 | 23.24 | +0.72 |
Ellington Financial E Pref | EFC-E | Sep 20, 2024 | 25.29 | -2.28 |
Ellington Financial Pref | EFC-C | Sep 20, 2024 | 25.42 | 0.00 |
Ellington Residential Mortgage REIT | EARN | Sep 20, 2024 | 7.01 | 0.00 |
Ellomay Capital | ELLO | Sep 20, 2024 | 11.95 | 0.00 |
Ellsworth Growth | ECF | Sep 20, 2024 | 9.00 | +0.67 |
Ellsworth Growth A | ECF-A | Sep 20, 2024 | 23.84 | -1.24 |
Elme Communities | ELME | Sep 20, 2024 | 17.79 | -0.73 |
Eltek | ELTK | Sep 20, 2024 | 11.02 | -0.36 |
Elutia | ELUT | Sep 20, 2024 | 4.00 | +4.44 |
Embecta | EMBC | Sep 20, 2024 | 15.61 | -0.64 |
Embotelladora Andina ADR | AKO-A | Sep 20, 2024 | 14.50 | -2.03 |
Embotelladora Andina ADR | AKO-B | Sep 20, 2024 | 18.91 | +3.05 |
Embrace Change Acquisition | EMCG | Sep 20, 2024 | 11.52 | 0.00 |
Embrace Change Acquisition Unit | EMCGU | Sep 20, 2024 | 11.70 | 0.00 |
Embraer ADR | ERJ | Sep 20, 2024 | 35.10 | +0.86 |
EMCOR Group | EME | Sep 20, 2024 | 435.60 | +1.29 |
Emcore | EMKR | Sep 20, 2024 | 1.14 | +4.59 |
Emerald Holding | EEX | Sep 20, 2024 | 4.40 | -6.18 |
Emeren ADR | SOL | Sep 20, 2024 | 2.25 | +0.90 |
Emergent BioSolutions | EBS | Sep 20, 2024 | 6.55 | -6.29 |
Emerson Electric | EMR | Sep 20, 2024 | 105.16 | -0.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.